Medicines and Healthcare products Regulatory AgencyMedicines and Healthcare products Regulatory Agency

MHRA approves UK’s first anti-PD-1 monoclonal antibody for treatment of aggressive form of lung cancer – uk.gov

by
MHRA approves UK’s first anti-PD-1 monoclonal antibody for treatment of aggressive form of lung cancer – uk.gov

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 20 June 2025, approved serplulimab (Hetronifly) to treat adults with extensive-stage small cell lung cancer (ES-SCLC), which has not previously been treated, and has spread within the lungs or to other parts of the body.  SCLC is a fast-growing cancer that typically develops in the … Read more

Sotatercept approved to treat adult patients with pulmonary arterial hypertension (PAH) – uk.gov

by
Sotatercept approved to treat adult patients with pulmonary arterial hypertension (PAH) – uk.gov

Sotatercept is used, in combination with other medicines to treat PAH, in adults with moderate or marked limitations of physical activity, to improve exercise capacity. Patients with pulmonary arterial hypertension have high blood pressure in the blood vessels that supply the lungs (pulmonary arteries). It’s a rare and serious condition that can damage the right … Read more

Patients could have faster access to ground-breaking stem cell treatment with manufacturing innovation – uk.gov

by
Patients could have faster access to ground-breaking stem cell treatment with manufacturing innovation – uk.gov

The safe manufacture of potentially life-saving stem cells through innovative automation and machine learning, could give patients faster access to stem cell treatments in the future. Today, experts and UKSCB alumni are meeting for a special event at the Medicines and Healthcare products Regulatory Agency’s South Mimms Laboratories to celebrate two decades of supporting innovation … Read more